Industry News: Namocell partners with OLS to expand distribution to Germany and Austria

18 Mar 2021

Namocell has announced it has entered into a distribution agreement with Germany-based OLS OMNI Life Science to distribute Namocell’s Single Cell Dispensers in Germany and Austria.

“There has been significant demand for our Single Cell Dispensers in Germany and Austria,” said Namocell CEO Dr. Junyu Lin. “OLS is a leading player in the Germany and Austria markets with strong track record in distributing cell research and development products and delivering outstanding customer services. We are excited to partner with OLS to bring our innovative single-cell isolation technology to more researchers there.”

“Namocell’s industry-leading single-cell isolation instruments are a game-changer for cell line engineering and development, CRISPR, single-cell genomics, antibody development, and other single-cell applications. The Namocell Single Cell Dispenser is fast, gentle, and very easy to use. It enables researchers to sort and dispense single cells within minutes while preserving cell viability and integrity, so you can get excellent outgrowth and better data. It can handle sample input ranging from 100 cells to 150 million cells/mL. The versatility offers an ideal solution no matter you have precious clinical samples or want to isolate extremely rare cells from a large number of cells,” said Dr. Andreas Friese, OLS COO. “We are very excited to bring these innovative high-performance instruments to more labs in Germany and Austria. We look forward to offering an expanded cell research portfolio to further strengthen our position as a partner in cell research.”

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>